Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 8:00 ...
On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...
Discover insights on Carlyle Credit Income Fund's new 7.375% Series D Preferred Shares & compare yields. Click for more on ...
Getting monetary policy right requires looking at near- and medium-term economic impacts of cyclical and secular forces, ...
Members of the diplomatic community, business and industry representatives, the K92 Board of Directors, project partners and industry peers were also in attendance. As at September 30, 2025, 90% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback